Medical Disposables & Supplies Limited (JMSE:MDS)
Jamaica · Delayed Price · Currency is JMD 0.9200
0.00 (0.00%)
At close: Jul 21, 2026
JMSE:MDS Financials Overview
Financials in millions JMD. Fiscal year is April - March.
Millions JMD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue Revenue Growth | 3,943 | 3,884 | 3,709 | 3,770 | 3,416 | 2,423 |
Revenue Growth | 1.53% | 4.71% | -1.60% | 10.35% | 41.01% | -2.35% |
Gross Profit Gross Profit Growth | 867.71 | 876.43 | 713.9 | 1,014 | 936.46 | 598.89 |
Operating Income Operating Income Growth | -154.16 | -151.66 | -175.27 | 195.72 | 221.8 | 94.45 |
Net Income Net Income Growth | -179.94 | -201.83 | -292.09 | 72.14 | 96.97 | 69.61 |
Earnings Per Share EPS Growth | -0.67 | -0.77 | -1.11 | 0.27 | 0.37 | 0.26 |
EPS Growth | - | - | - | -25.61% | 39.29% | 101.45% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceutical Pharmaceutical Growth | 2,676 | 2,647 | 2,665 | 2,364 |
Consumables Consumables Growth | 475.53 | 371.69 | 395.34 | 587.67 |
Medical Medical Growth | 732.43 | 691.02 | 709.06 | 464.91 |
Total Total Growth | 3,884 | 3,709 | 3,770 | 3,416 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Investments Cash & Investments Growth | 47.45 | 50.93 | 118.06 | 141.51 | 145.7 | 116.64 |
Total Debt Total Debt Growth | 989.72 | 1,081 | 1,096 | 996.47 | 980.43 | 654.31 |
Net Cash (Debt) Net Cash Growth | -942.27 | -1,030 | -977.73 | -854.95 | -834.73 | -537.67 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.51 | -3.91 | -3.72 | -3.25 | -3.17 | -2.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -22.41 | -46.2 | -79.41 | 44.08 | -159.63 | -9.69 |
Capital Expenditures CapEx Growth | -12.94 | -5.81 | -12.41 | -33.1 | -1.97 | -10.77 |
Free Cash Flow Free Cash Flow Growth | -35.35 | -52.01 | -91.83 | 10.98 | -161.6 | -20.46 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Gross Margin | 22.00% | 22.56% | 19.25% | 26.89% | 27.41% | 24.72% |
Operating Margin | -3.91% | -3.91% | -4.72% | 5.19% | 6.49% | 3.90% |
Pretax Margin | -6.58% | -7.32% | -8.64% | 2.57% | 4.29% | 3.13% |
Profit Margin | -4.56% | -5.20% | -7.88% | 1.91% | 2.84% | 2.87% |
FCF Margin | -0.90% | -1.34% | -2.48% | 0.29% | -4.73% | -0.84% |
| Fiscal Year | FY 2022 | FY 2021 |
|---|---|---|
| Period Ending | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.090 | 0.070 |
Dividend Per Share Growth | 28.57% | - |
Dividend Yield | 1.51% | 1.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | - | - | - | 18.06 | 16.42 | 15.69 |
P/FCF Ratio | - | - | - | 118.61 | - | - |
PS Ratio | 0.06 | 0.12 | 0.18 | 0.35 | 0.47 | 0.45 |